What question did this study set out to answer?

To assess the incidence of thrombotic complications, particularly venous thromboembolism, and the potential protective role of heparin in hospitalized patients with Covid-19.

August 4, 2021New England Journal of MedicineOpen Access

Surviving Covid-19 with Heparin?

View Full Paper

Ask AI

Bookmark

To assess the incidence of thrombotic complications, particularly venous thromboembolism, and the potential protective role of heparin in hospitalized patients with Covid-19.
Meta-analysis synthesizing evidence across 66 clinical studies of patients hospitalized with Covid-19.
Hospitalized Covid-19 cohorts exhibit a high burden of vascular clotting events, with venous thromboembolism occurring at elevated rates.
Heparin administration acts as a targeted anticoagulant strategy to counteract hypercoagulability and reduce thrombotic complications.

Implication

Meta-analysis reveals high venous thromboembolism rates in hospitalized Covid-19 patients, highlighting the value of heparin anticoagulation.

Abstract

Patients who are admitted to the hospital with coronavirus disease 2019 (Covid-19) are at high risk for thrombosis, particularly venous thromboembolism (VTE). In a meta-analysis of 66 studies, the ...

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Hugo Ten Cate (2021) studied this question.

synapsesocial.com/papers/69d806aa45af6083e6ae2a2a https://doi.org/10.1056/nejme2111151

View Full Paper

Ask AI

Bookmark

Implication

Meta-analysis reveals high venous thromboembolism rates in hospitalized Covid-19 patients, highlighting the value of heparin anticoagulation.

Surviving Covid-19 with Heparin?

Key Points

Implication

Abstract

Discussion

Cite This Study

Surviving Covid-19 with Heparin?

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading